Intraoperative Imaging-Guided Cancer Surgery: From Current Fluorescence Molecular Imaging Methods to Future Multi-Modality Imaging Technology
TL;DR: The current intraoperative optical molecular imaging technologies, focusing on contrast agents and surgical navigation systems, and the future prospects of multi-modality imaging technology for intraoperative imaging-guided cancer surgery are reviewed.
read more
Abstract: Cancer is a major threat to human health. Diagnosis and treatment using precision medicine is expected to be an effective method for preventing the initiation and progression of cancer. Although anatomical and functional imaging techniques such as radiography, computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) have played an important role for accurate preoperative diagnostics, for the most part these techniques cannot be applied intraoperatively. Optical molecular imaging is a promising technique that provides a high degree of sensitivity and specificity in tumor margin detection. Furthermore, existing clinical applications have proven that optical molecular imaging is a powerful intraoperative tool for guiding surgeons performing precision procedures, thus enabling radical resection and improved survival rates. However, detection depth limitation exists in optical molecular imaging methods and further breakthroughs from optical to multi-modality intraoperative imaging methods are needed to develop more extensive and comprehensive intraoperative applications. Here, we review the current intraoperative optical molecular imaging technologies, focusing on contrast agents and surgical navigation systems, and then discuss the future prospects of multi-modality imaging technology for intraoperative imaging-guided cancer surgery.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Tumor Accumulation and Off-Target Biodistribution of an Indocyanine-Green Fluorescent Nanotracer: An Ex Vivo Study on an Orthotopic Murine Model of Breast Cancer.
TL;DR: In this article, 24 monomers of H-Ferritin (HFn) self-assemble into a spherical cage structure enclosing the indocyanine green fluorescent tracer and display tumor homing due to the specific interaction between the HFn nanocage and transferrin receptor 1.
Image-Guided Tumor Resection.
TL;DR: Recent advances related to developing targeted fluorescent agents to guide surgeons during cancer removal are reviewed, with the goal of clearly distinguish cancer from normal tissue to improve surgical outcome for cancer patients.
Improved Tumor Targeting and Longer Retention Time of NIR Fluorescent Probes Using Bioorthogonal Chemistry.
Xianghan Zhang,Bo Wang,Zhao Na,Zuhong Tian,Yunpeng Dai,Yongzhan Nie,Jie Tian,Jie Tian,Zhongliang Wang,Xiaoyuan Chen +9 more
TL;DR: The click-chemistry-assisted detection strategy utilizes the advantages of “small molecule” probes while not perturbing their physiological functions; this enables tumor detection with high sensitivity and specific selectivity.
Advances in Early Detection and Diagnostic Adjuncts in Oral Cavity Cancer
Camile S. Farah,Nirav Bhatia,Yastira Lalla,An Vu,Keziah John,Vishal Gupta,John Baeten,Alexander Johnson,Deepak Kademani +8 more
- 01 Jan 2017
TL;DR: Oral and pharyngeal cancers combined rank within the top ten most common malignancies in the world for men, with an estimated global incidence of oral cancer alone at approximately 275,000 per year.
Cellular localization of iron(II) polypyridyl complexes determines their anticancer action mechanisms.
TL;DR: It is shown that the cellular localization of Fe(II) complexes regulated by their lipophilicity could affect the anticancer efficacy and action mechanisms, and may enhance the understanding on the rational design of the next-generation anticancer metal complexes.
References
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes.
TL;DR: In vivo imaging showed a 12-fold increase in NIRF signal, allowing the detection of tumors with submillimeter-sized diameters, and this strategy can be used to detect such early stage tumors in vivo and to probe for specific enzyme activity.
1.7K
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
Gooitzen M. van Dam,George Themelis,Lucia M. A. Crane,Niels J. Harlaar,Niels J. Harlaar,Rick G. Pleijhuis,W. Kelder,Athanasios Sarantopoulos,Johannes S. de Jong,Henriette J. G. Arts,Ate G.J. van der Zee,Joost Bart,Philip S. Low,Vasilis Ntziachristos +13 more
TL;DR: In patients with ovarian cancer, intraoperative tumor-specific fluorescence imaging with an FR-α–targeted fluorescent agent showcased the potential applications in patients with Ovarian cancer for improved intraoperative staging and more radical cytoreductive surgery.
1.5K
Image-guided cancer surgery using near-infrared fluorescence.
Alexander L. Vahrmeijer,Merlijn Hutteman,Joost R. van der Vorst,Cornelis J. H. Van De Velde,John V. Frangioni +4 more
TL;DR: The concept of NIR fluorescence imaging for cancer surgery is introduced, the clinical trial literature to date is examined, and the key issues pertaining to imaging system and contrast agent optimization are outlined.
A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle
Moritz F. Kircher,Adam de la Zerda,Jesse V. Jokerst,Cristina Zavaleta,Paul J. Kempen,Erik Mittra,Kenneth L. Pitter,Ruimin Huang,Carl Campos,Frezghi Habte,Robert Sinclair,Cameron Brennan,Ingo K. Mellinghoff,Ingo K. Mellinghoff,Eric C. Holland,Sanjiv S. Gambhir +15 more
TL;DR: It is shown that a unique triple-modality magnetic resonance imaging–photoacoustic imaging–Raman imaging nanoparticle approach can accurately help delineate the margins of brain tumors in living mice both preoperatively and intraoperatively.
What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer
Iris D. Nagtegaal,Phil Quirke +1 more
TL;DR: It is demonstrated that, after neoadjuvant therapy (both radiotherapy and radiochemotherapy), the predictive value of the CRM for local recurrence is significantly higher than when no preoperative therapy has been applied and involvement is one of the key factors in rectal cancer treatment.
1K